At Medica 2014 in Dusseldorf, Germany (hall 10, booth A20), Siemens showcases its latest innovations in ultrasound. The main focus of this year's exhibition is the new version of Siemens' premium cardiovascular ultrasound imaging system – the Acuson SC2000 PRIME edition - now with live volume 3D transesophageal echo (TEE) imaging.
For a broad range of clinical specialties at an excellent price/performance ratio, Siemens shows the new Acuson X600 ultrasound system, ideal for obstetrics and gynecology, and a new version of the Acuson X700 system, featuring premium technologies for more clinical applications.
Better view of dynamic blood flow during interventional valve procedures
The new release of the premium Acuson SC2000 ultrasound system, PRIME edition for cardiovascular imaging is the first to offer live full-volume color Doppler imaging of heart valve anatomy and blood-flow using the new Z6Ms true volume TEE probe. With this technology, physicians can obtain a more anatomically accurate view of the heart and dynamic blood flow in one view during interventional valve procedures, even in patients with ECG abnormalities.
Current methods of imaging with 3D TEE require stitching – the fusion of multiple heartbeats – to form a complete image of heart function and blood flow. This gated acquisition eliminates almost all patients with any ECG abnormalities and often results in image artifacts, which may skew results. However, the new Z6Ms true volume TEE probe on the Acuson SC2000 PRIME is the first Siemens transducer touse true volume 3D TEE with 90° x 90° real-time acquisition and volume color Doppler, enabling full 3D images of the heart, in every heartbeat without stitching. By eliminating the need for multiple beats to form an image and adding volume color Doppler capabilities, the Z6Ms true volume TEE probe allows the surgeon to visualize and assess blood flow in real-time during a procedure to make sure the repaired or replaced valve is working properly, potentially reducing the need for a secondary intervention to correct any remaining regurgitation. The new technology is also available as an upgrade for users of previous versions of the Acuson SC2000 system.
Reliability and performance for general imaging demands in ultrasound
The new Acuson X600 ultrasound system – the latest addition to the Acuson X Family of mid-range ultrasound systems – enhances image quality, reliability and performance in its price class. Engineered on a robust system architecture, the Acuson X600 system is an affordable ultrasound solution with advanced, state-of-the-art technologies and workflow efficiencies migrated from premium systems.
The Acuson X600 system is equipped with many advanced imaging technologies such as real time spatial compounding and Dynamic TCE tissue contrast enhancement technology for reduction of artifacts and improved border detection, thus offering improved detail and contrast resolution. Three new volume transducers included on the system provide enhanced 3D/4D image quality for clear visualization of complex fetal and maternal anatomy. The system includes several knowledge-based productivity applications such as syngo AutoOB, which simplifies biometrics measurements of six major fetal structures*. This application saves up to 75 percent of key strokes** and provides a consistency in data measurement, thus increasing speed of exam and decreasing operator fatigue and risk of repetitive strain injuries.
Enhanced Features in Acuson X700 version 2.0
The Acuson X700 system is a shared-service ultrasound platform that leverages innovative imaging technologies for reliable performance across a broad range of clinical applications at an excellent price/performance ratio. The new version of the Acuson X700 system adds more premium technologies, like eSie Touch elasticity imaging technology, which provides physicians with more clinical information to differentiate benign and malignant tissue in the abdomen and small parts. Built-in features like micro-pinless (MP) transducer connectors and customizable upgrades make it easy to update the system as clinical needs evolve.
*CRL, BPD, HL, HC, AC, and FL
**Results may vary: Data on file.
For further information on Acuson SC2000, Prime edition please see http://www.siemens.com/press/pi/HCP201408028e
For further information on Ultrasound, please see http://www.healthcare.siemens.com/
Siemens AG (Berlin and Munich) is a global technology powerhouse that has stood for engineering excellence, innovation, quality, reliability and internationality for more than 165 years. The company is active in more than 200 countries, focusing on the areas of electrification, automation and digitalization. One of the world's largest producers of energy-efficient, resource-saving technologies, Siemens is No. 1 in offshore wind turbine construction, a leading supplier of combined cycle turbines for power generation, a major provider of power transmission solutions and a pioneer in infrastructure solutions as well as automation, drive and software solutions for industry. The company is also a leading provider of medical imaging equipment – such as computed tomography and magnetic resonance imaging systems – and a leader in laboratory diagnostics as well as clinical IT. In fiscal 2014, which ended on September 30, 2014, Siemens generated revenue from continuing operations of €71.9 billion and net income of €5.5 billion. At the end of September 2014, the company had around 357,000 employees worldwide. Further information is available on the Internet at http://www.siemens.com
The products/features here mentioned are not commercially available in all countries. Due to regulatory reasons their future availability cannot be guaranteed. Please contact your local Siemens organization for further details.
Reference Number: PR2014110040HCEN
Ms. Anja Uhlendorff
Tel: +49 (9131) 84-6188
Anja Uhlendorff | Siemens Healthcare
An MRI technique has been developed to improve the detection of tumors
03.06.2020 | Moscow Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies
High-resolution 3D view inside breast tumors with opto-acoustic mesoscopy
27.05.2020 | Technische Universität München
Humans rely dominantly on their eyesight. Losing vision means not being able to read, recognize faces or find objects. Macular degeneration is one of the major...
In meningococci, the RNA-binding protein ProQ plays a major role. Together with RNA molecules, it regulates processes that are important for pathogenic properties of the bacteria.
Meningococci are bacteria that can cause life-threatening meningitis and sepsis. These pathogens use a small protein with a large impact: The RNA-binding...
An analysis of more than 200,000 spiral galaxies has revealed unexpected links between spin directions of galaxies, and the structure formed by these links...
Two prominent X-ray emission lines of highly charged iron have puzzled astrophysicists for decades: their measured and calculated brightness ratios always disagree. This hinders good determinations of plasma temperatures and densities. New, careful high-precision measurements, together with top-level calculations now exclude all hitherto proposed explanations for this discrepancy, and thus deepen the problem.
Hot astrophysical plasmas fill the intergalactic space, and brightly shine in stellar coronae, active galactic nuclei, and supernova remnants. They contain...
In living cells, enzymes drive biochemical metabolic processes enabling reactions to take place efficiently. It is this very ability which allows them to be used as catalysts in biotechnology, for example to create chemical products such as pharmaceutics. Researchers now identified an enzyme that, when illuminated with blue light, becomes catalytically active and initiates a reaction that was previously unknown in enzymatics. The study was published in "Nature Communications".
Enzymes: they are the central drivers for biochemical metabolic processes in every living cell, enabling reactions to take place efficiently. It is this very...
19.05.2020 | Event News
07.04.2020 | Event News
06.04.2020 | Event News
05.06.2020 | Life Sciences
05.06.2020 | Physics and Astronomy
05.06.2020 | Life Sciences